Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Improved CRBN ligands make protein degraders more effective and drug-like.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

Finasteride may reduce prostate cancer risk.

Targeting NETs may help reduce fibrosis in Crohn's disease.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

The trial on testosterone replacement therapy in older men faced concerns due to prostate cancer risk.

[6]-Gingerdiol 3-monoacetate shows promise for treating T. whipplei infections.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

4‐MAPC reduces rat prostate weight and prostatein levels.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

LGD1069 effectively prevents breast tumors in mice without toxicity.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Isotretinoin shows promise as a treatment for Chagas disease by effectively inhibiting key transporters in the parasite.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

TRPA1 and TRPV1 channels don't affect mechanotransduction in rat sinus hair follicles.